Relocation to Kyiv, transition to a new business model of work, contract production, restoration of production facilities, transition to the development stage, release of new drugs, and most importantly – preservation of the team and scientific potential. Read more about our experience in the interview with the CEO of Microkhim Klym Tymko at the link: https://www.apteka.ua/article/693222